Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality?
Warmuth, I.; Moore, P.S.
Archives of Dermatology 133(1): 83-85
1997
ISSN/ISBN: 0003-987X PMID: 9006376 Document Number: 475268
Document emailed within 1 workday
Related Documents
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Parfenova, T.M.; Morozov, V.A.; Il'in, K.V.; Chistiakova, I.A.; Samsonov, V.A.; Averina, A.V.; Kakezaĭ, I.A.; Bykovskiĭ, A.F. 1994: Detection of markers of the human T-cell leukemia virus in patients with T-cell lymphoma and Kaposi's sarcoma Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 5: 13-17
Plettenberg, A.; Albrecht, D.; Lorenzen, T.; Meyer, T.; Arndt, R.; Stoehr, A. 2002: Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma European Journal of Medical Research 7(1): 19-24
Pozo, F.; Tenorio, A.; de la Mata, M.; de Ory, F.; Torre-Cisneros, J. 2000: Persistent human herpesvirus 8 viremia before Kaposi's sarcoma development in a liver transplant recipient Transplantation 70(2): 395-397
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
1991: Endemic Kaposi's sarcoma in human immunodeficiency virus type 1 seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions Disease Markers 9(2): 120
Chandra, A.; Demirhan, I.; Massambu, C.; Pyakurel, P.; Kaaya, E.; Enbom, M.; Urassa, W.; Linde, A.; Heiden, T.; Biberfeld, P.; Doerr, H.W.; Cinatl, J.; Loewer, J.; Chandra, P. 2003: Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients Anticancer Research 23(1b): 723-728
Santón Roldán, A.; De San José, S.; Gómez Sanz, E.; Fernández Muñoz, R.; Herrera, P.; Bellas Menéndez, C. 2002: Human herpesvirus-8 detection in Kaposi's sarcoma, multiple myeloma, and lymphoproliferative syndromes occurring in immunocompetent and immunocompromised patients Medicina Clinica 119(7): 241-244
Caterino-de-Araujo, A.; Magri, M.C.; Manuel, R.C.R. 2010: Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique Journal of Medical Virology 82(9): 1576-1581
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663
Bahia; Brites 1999: Human Herpes Virus 8 and Kaposi's Sarcoma: a Review Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(5): 166-175
Gürtler, L. 1995: Kaposi sarcoma apparently induced by a new oncogenic herpesvirus Fortschritte der Medizin 113(22-23): 7-8
Malope, B.I.; MacPhail, P.; Mbisa, G.; MacPhail, C.; Stein, L.; Ratshikhopha, E.M.; Ndhlovu, L.; Sitas, F.; Whitby, D. 2008: No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population Aids 22(4): 519-526
Blel, A.; Debbebi, B.; Azouz, H.; Zeddini, A.; Goucha, A.ïd.; Maamouri, F.; Gamoudi, A.; El May, A. 2008: Oropharyngeal Kaposi's sarcoma: about a case not associated to the human immunodeficiency virus La Tunisie Medicale 86(6): 620-621
Lin, C.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Lo, Y.-C.; Hung, C.-C.; Chang, S.-C. 2009: Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan Journal of Microbiology Immunology and Infection 42(3): 227-233
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Hsieh, M-Chun.; Chiu, N-Chang.; Chi, H.; Huang, F-Yuan. 2007: Hepatosplenic Kaposi's sarcoma as the initial presentation in a Taiwanese child with human immunodeficiency virus infection Acta Paediatrica Taiwanica 48(2): 84-88
Agaoglu, F.Y.; Dizdar, Y.; Basaran, M.; Bilgic, B.; Darendeliler, E. 2004: Human immunodeficiency virus-negative tonsil Kaposi's sarcoma and Hodgkin's disease: case report and review of the literature Journal of BUON: Official Journal of the Balkan Union of Oncology 9(3): 321-324